292 related articles for article (PubMed ID: 26097587)
1. Cullin1 is up-regulated and associated with poor patients' survival in hepatocellular carcinoma.
Liu W; Wang Y; Zhang C; Huang B; Bai J; Tian L
Int J Clin Exp Pathol; 2015; 8(4):4001-7. PubMed ID: 26097587
[TBL] [Abstract][Full Text] [Related]
2. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma.
Pan LH; Yao M; Cai Y; Gu JJ; Yang XL; Wang L; Yao DF
World J Gastroenterol; 2016 Apr; 22(14):3829-36. PubMed ID: 27076768
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Cullin1 is associated with poor prognosis of patients with gastric cancer.
Bai J; Zhou Y; Chen G; Zeng J; Ding J; Tan Y; Zhou J; Li G
Hum Pathol; 2011 Mar; 42(3):375-83. PubMed ID: 21190721
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implication of NQO1 overexpression in hepatocellular carcinoma.
Lin L; Sun J; Tan Y; Li Z; Kong F; Shen Y; Liu C; Chen L
Hum Pathol; 2017 Nov; 69():31-37. PubMed ID: 28964792
[TBL] [Abstract][Full Text] [Related]
6. High expression of Cullin1 indicates poor prognosis for NSCLC patients.
Xu M; Yang X; Zhao J; Zhang J; Zhang S; Huang H; Liu Y; Liu J
Pathol Res Pract; 2014 Jul; 210(7):397-401. PubMed ID: 24767980
[TBL] [Abstract][Full Text] [Related]
7. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of activated Cdc42-associated kinase1 (Ack1) predicts tumor recurrence and poor survival in human hepatocellular carcinoma.
Wang B; Xu T; Liu J; Zang S; Gao L; Huang A
Pathol Res Pract; 2014 Dec; 210(12):787-92. PubMed ID: 25445114
[TBL] [Abstract][Full Text] [Related]
10. DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer.
Song LJ; Liu Q; Meng XR; Li ShL; Wang LX; Fan QX; Xuan XY
Diagn Pathol; 2016 Feb; 11():19. PubMed ID: 26846339
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma.
Yan TH; Yang H; Jiang JH; Lu SW; Peng CX; Que HX; Lu WL; Mao JF
Int J Clin Exp Pathol; 2015; 8(4):4126-31. PubMed ID: 26097602
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.
Ji F; Fu SJ; Shen SL; Zhang LJ; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP
BMC Cancer; 2015 Mar; 15():116. PubMed ID: 25880619
[TBL] [Abstract][Full Text] [Related]
13. The expression of Cullin1 is increased in renal cell carcinoma and promotes cancer cell proliferation, migration, and invasion.
Ping JG; Wang F; Pu JX; Hou PF; Chen YS; Bai J; Zheng JN
Tumour Biol; 2016 Sep; 37(9):12823-12831. PubMed ID: 27449035
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of cytoskeleton-associated membrane protein 4 and its palmitoyl acyltransferase DHHC2 in hepatocellular carcinoma.
Li SX; Tang GS; Zhou DX; Pan YF; Tan YX; Zhang J; Zhang B; Ding ZW; Liu LJ; Jiang TY; Hu HP; Dong LW; Wang HY
Cancer; 2014 May; 120(10):1520-31. PubMed ID: 24863391
[TBL] [Abstract][Full Text] [Related]
15. ALK gene copy number gain and its clinical significance in hepatocellular carcinoma.
Jia SW; Fu S; Wang F; Shao Q; Huang HB; Shao JY
World J Gastroenterol; 2014 Jan; 20(1):183-92. PubMed ID: 24415871
[TBL] [Abstract][Full Text] [Related]
16. ITPKA expression is a novel prognostic factor in hepatocellular carcinoma.
Li J; Zhu YH; Huang P; Zhang B; Sun J; Guan XY
Diagn Pathol; 2015 Aug; 10():136. PubMed ID: 26249031
[TBL] [Abstract][Full Text] [Related]
17. RMP predicts survival and adjuvant TACE response in hepatocellular carcinoma.
Zhang J; Jiang TY; Jiang BG; Yang C; Tan YX; Yang N; Pan YF; Ding ZW; Yang GZ; Wu MC; Dong LW; Wang HY
Oncotarget; 2015 Feb; 6(5):3432-42. PubMed ID: 25605019
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of KIF1B mRNA in hepatocellular carcinoma tissues correlates with poor prognosis.
Yang SZ; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG
World J Gastroenterol; 2015 Jul; 21(27):8418-24. PubMed ID: 26217094
[TBL] [Abstract][Full Text] [Related]
19. SESN2 correlates with advantageous prognosis in hepatocellular carcinoma.
Chen S; Yan W; Lang W; Yu J; Xu L; Xu X; Liu Y; Bao H
Diagn Pathol; 2017 Jan; 12(1):13. PubMed ID: 28118855
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of KIF23 variant 1 expression and relevance as a novel prognostic factor in patients with hepatocellular carcinoma.
Sun X; Jin Z; Song X; Wang J; Li Y; Qian X; zhang Y; Yin Y
BMC Cancer; 2015 Dec; 15():961. PubMed ID: 26674738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]